Retatrutide Before FDA Approval? Lilly Just Changed the Conversation
From On The Pen GLP-1 News · · 20 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Dave breaks down an unreported Expanded Access Pathway that Eli Lilly has quietly established for Retatrutide.